Summary by Moomoo AI
Aditxt Inc. received a Nasdaq delisting notice on March 7, 2025, due to bid price falling below $0.10, prompting an appeal and implementation of a 1:250 reverse stock split. The company has raised significant capital in Q1 2025, securing $16.2M through ELOC financing at $18.99 per share average and $4.58M via ATM offering at $25.76 per share average. Current unaudited equity stands at approximately $10M, meeting Nasdaq requirements.The company has made substantial progress in debt management, clearing multiple unsecured promissory notes and settling obligations with Aldevron through a $1M immediate payment and $824,371 promissory note. Additionally, Aditxt redeemed 6,110 shares of Series C-1 Preferred Stock for $7.03M, with 2,263 shares still outstanding for redemption at $2.60M.Strategic developments include the acquisition of DNA adduct detection patents from Pearsanta and an ongoing merger process with Evofem, extended to September 30, 2025. The company must invest an additional $1.5M by April 7, 2025, while a Special Meeting is scheduled for April 17, 2025, to vote on key share issuance proposals.
Comment(0)
Reason For Report